Genosyn vs. BioGenic: Biotech’s 2026 Patent Wars
A gene-editing patent war between Genosyn and BioGenic shows risks for biotech innovation. Learn how such lawsuits impact R&D, costing over $5 million.
A gene-editing patent war between Genosyn and BioGenic shows risks for biotech innovation. Learn how such lawsuits impact R&D, costing over $5 million.
Can Small Modular Reactors power our future? See how new nuclear policies, including tax credits, aim to meet 2026 energy needs.
New IAEA policy tackles stalled nuclear plant expansion. Learn how global conferences and policy decisions aim to meet 2026 decarbonization goals.
Why currency devaluation drives smuggling, how it hurts economies, and what governments can do. Understand the 2026 forecast.
Will new drug pricing policies save patients money by 2026? Learn how the IRA affects costs, innovation, and Medicare's 10 negotiated drugs.
New 2026 cybersecurity laws demand companies disclose zero-day exploits within 72 hours. Avoid fines up to 5% of revenue. What's next?
Is nuclear energy poised for a comeback? Billions are pouring into advanced reactors like SMRs. See if 2026 signals a true renaissance.
Iran's black market hits 15% of GDP by 2024 IMF data. See how illicit trade impacts regional economies and why sanctions fuel its growth.
KB Home's Q4 miss points to a tough 2027 housing market. See why demand is down, prices are falling, and what homebuyers can expect.
New 2025 procurement rules impact contractors like Jenkins Construction. See how 15% material cost hikes affect public works projects now.